Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis

International Journal of Oncology

Volumn 33, Issue 2, 2008, Pages 361-370

  Tanaka, Satoru ^a   Sakai, Akiko ^a   Kimura, Kousei ^a   Yoshida, Hideji ^a   Fushitani, Hideo ^a   Ogata, Akihito ^a   Miyamoto, Akiko ^a   Fukushima, Masakazu ^b   Wada, Akira ^a,c   Tanigawa, Nobuhiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c Yoshida Biological Laboratory   (Japan)

Author keywords

5 FU; Colon cancer; Drug resistance; Proteome; RFHR 2 D PAGE

Indexed keywords

BIOLOGICAL MARKER; FLUOROURACIL; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN G; HISTONE H2B; HISTONE H4; MITOCHONDRIAL TRANSCRIPTION FACTOR A; RIBOSOME PROTEIN; RIBOSOME PROTEIN L; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE STUDY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUOROURACIL; HUMANS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 48749111676     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000016     Document Type: Article

References (40)

1. Miwa M, Ura M, Nishida M, Sawada N, Ishikawa T, Mori K, Shimma N, Umeda I and Ishitsuka H: Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer 34: 1274-1281, 1998.
2. Rich TA, Shepard RC and Mosley ST: Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. J Clin Oncol 22: 2214-2232, 2004.
3. Chau I and Cunningham D: Chemotherapy in colorectal cancer: new options and new challenges. Br Med Bull 64: 159-180, 2002.
4. Royce ME, Medgyesy D, Zukowski TH, Dwivedy S, Hoff PM and Pazdur R: Colorectal cancer: chemotherapy treatment overview. Oncology 14: 40-46, 2000.
5. Zembutsu H, Ohnishi Y, Tsunoda T, Furukawa Y, Katagiri T, Ueyama Y, Tamaoki N, Nomura T, Kitahara O, Yanagawa R, Hirata K and Nakamura Y: Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human caner xenografts to anticancer drugs. Cancer Res 62: 518-527, 2002.
6. Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, Kitahara O, Zembutsu H, Yanagawa R, Hirata K, Takagi T and Nakamura Y: Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 61: 6474-6479, 2001.
7. Kang HC, Kim IJ, Park JH, Shin Y, Ku JL, Jung MS, Yoo BC, Kim HK and Park JG: Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res 10: 272-284, 2004.
8. Yoo BC, Jeon E, Hong SH, Shin YK, Chang HJ and Park JG: Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line. Clin Cancer Res 10: 4176-4184, 2004.
9. Shin YK, Yoo BC, Chang HJ, Jeon E, Hong SH, Jung MS, Lim SJ and Park JG: Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res 65: 3162-3170, 2005.
10. Wada A: Analysis of Escherichia coli ribosomal proteins by an improved two dimensional gel electrophoresis. I. Detection of four new proteins. J Biochem 100: 1583-1594, 1986.
11. Wada A: Analysis of Escherichia coli ribosomal proteins by an improved two dimensional gel electrophoresis. II. Characterization of four new proteins. J Biochem 100: 1595-1605, 1986.
12. Longley DB, Harkin DP and Johnston PG: 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3: 330-338, 2003.
13. Murakami Y, Kazuno H, Emura T, Tsujimoto H, Suzuki N and Fukushima M: Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. Int J Oncol 17: 277-283, 2000.
14. Carmichael J, De Graff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of tetrazolium-based semiautomated colorimetric assay: assesment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
15. Madjar JJ: Preparation of ribosomes and ribosomal proteins from cultured cells. In: Cell Biology. Celis JE (ed). Academic Press Inc., San Diego, pp657-661, 1994.
16. Hardy SJ, Kurland CG, Voynow P and Mora G: The ribosomal proteins of Escherichia coli. I. Purification of the 30S ribosomal proteins. Biochemistry 8: 2897-28905, 1969.
17. Kaltschmidt E and Wittmann HG: Ribosomal proteins. VII. Two-dimensional polyacrylamide gel electrophoresis for finger-printing of ribosomal proteins. Anal Biochem 36: 401-412, 1970.
18. Dreyfuss G, Matunis MJ, Piuol-Roma S and Burd CG: hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 62: 289-321, 1993.
19. Krecic AM and Swanson MS: hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11: 363-371, 1999.
20. Shin KH, Kim RH, Kang MK, Kim RH, Kim SG, Lim PK, Yochim JM, Baluda MA and Park NH: p53 promotes the fidelity of DNA end-joining activity by, in part, enhancing the expression of heterogeneous nuclear ribonucleoprotein G. DNA Repair 6: 830-840, 2007.
21. Bustin M: Regulation of DNA-dependent activities by the functional mofifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19: 5237-5246, 1999.
22. Reyes A, Mezzina M and Gadaleta G: Human mitochondrial transcription factor A (mtTFA): gene structure and characterization of related pseudogenes. Gene 291: 223-232, 2002.
23. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M, Harsh GS and Clayton DA: Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18: 231-236, 1998.
24. Wang J, Silva JP, Gustafsson CM, Rustin P and Larsson NG: Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci USA 98: 4038-4043, 2001.
25. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
26. Yoshida Y, Izumi H, Torigoe T, Ishiguchi H, Itoh H, Kang D and Kohno K: P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res 63: 3729-3734, 2003.
27. Imamura T, Izumi H, Nagatani G, Ise T, Nomoto M, Iwamoto Y and Kohno K: Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein. J Biol Chem 276: 7534-7540, 2001.
28. Pastukh V, Shokolenko I, Wang B, Wilson G and Alexeyev M: Human mitochondrial transcription factor A possesses multiple subcellular targeting signals. FEBS J 274: 6488-6499, 2007.
29. Ruggero D and Pandolfi PP: Does the ribosome translate cancer? Nat Rev Cancer 3: 179-192, 2003.
30. Popescu SC and Tumer NE: Silencing of ribosomal protein L3 genes in N. tabacum reveals coordinate expression and significant alterations in plant growth, development and ribosome biogenesis. Plant J 39: 29-44, 2004.
31. Bergqvist M, Brattström D, Brodin D, Lindkvist A, Dahlman-Wright K, Dreilich M, Wagenius G and Paulsson-Karlsson Y: Genes associated with telomerase activity levels in esophageal carcinoma cell lines. Dis Esophagus 19: 20-23, 2006.
32. Lingner J, Cooper JP and Cech TR: Telomerase and DNA end replication: no longer a lagging strand problem? Science 269: 1533-1534, 1995.
33. Dhaene K, van Marck E and Parwaresch R: Telomeres, telomerase and cancer: an up-date. Virchows Arch 437: 1-16, 2000.
34. Shay JW, Zou Y, Hiyama E and Wright WE: Telomerase and cancer. Hum Mol Genet 10: 677-685, 2001.
35. Kishimoto M, Fujiki R, Takezawa S, Sasaki Y, Nakamura T, Yamaoka K, Kitagawa H and Kato S: Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. Endocr J 53: 157-172, 2006.
36. Jenuwein T and Allis CD: Translating the histone code. Science 293: 1074-1080, 2001.
37. Fischle W, Wang Y and Allis CD: Binary switches and modification cassettes in histone biology and beyond. Nature 425: 475-479, 2003.
38. McKenna NJ and O'Malley BW: Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474, 2002.
39. Rachez C, Lemon BD, Suldan Z, Bromleigh V, Gamble M, Näär AM, Erdjument-Bromage H, Tempst P and Freedman LP: Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398: 824-828, 1999.
40. Fernandez-Capetillo O, Allis CD and Nussenzweig A: Phosphorylation of histone H2B at DNA double-strand breaks. J Exp Med 199: 1671-1677, 2004.